4Yamamoto T,Takagawa S,Katayama I,et al.Animal model of sclerotic skin.Ⅰ:Local injections of bleomycin induce sclerotic skin mimicking scleroderma.J Invest Dermatol,1999,112:456-462.
5Yamamoto T.Takagawa S,Katayama I,et al.Anti-sclerotic effect oftransforming growth factor- β antibody in a mousee model of bleomycin induced scleroderma.Clin Immunol,1999,92(1):6-13.
6Hunzelmann N,Anders S.Fierllbeck G,et al.Multicenter trial of 1 yearof treatment with recombinant interferon gamma.Arch Dermatol,1997,133(5):609-613.
7Yamamoto T,Takagawa S,Kuroda M,et al.Effect of interferon-ron exper-imental scleroderma induced by bleomycin.Arch Dermatol,2000,292:362-365.
8Black CM,Silman A J,Herrick AI,et al.Interferon-α does not improveoutcome at one year in patients with diffuse cutaneous scleroderma..Arthri-tis Rheum,1999,42:299-305.
10Peltonen J,Kahari L,Jaakkola S,et al.Evaluation of transforming growth facter β and type Ⅰ procollagen gene expression in fibrotic skin dieases by situ hybridization.J Invest Dermatol,1990,94(3):365-371.
